The Legislative Yuan approved the first reading of an amendment to a WTO agreement yesterday, which will allow Taiwanese pharmaceutical companies to make cheaper generic drugs for underdeveloped countries to combat fatal diseases such as HIV/AIDS, malaria and bird flu.
The WTO initiative, called Protocol Amending the Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS), will make it easier for poorer countries to import cheaper generic drugs made under compulsory licensing if they are unable to manufacture the medicines themselves.
The amendment to TRIPS Article 31 regarding compulsory licensing, which was approved by WTO member states in August 2005, authorizes pharmaceutical companies in WTO countries, if requested, to manufacture and export cheaper generic drugs to least developed countries, without having to pay the patent holders.
“Following the Cabinet’s approval of this amendment last month, the final approval from lawmakers will allow the government to report Taiwan’s TRIPS acceptance to the WTO Secretariat through Taiwan’s mission to WTO in Geneva,” said Wang Mei-hua (王美花), director-general of the Ministry of Economic Affairs’ Intellectual Property Office (IPO).
The WTO’s General Council has asked all member nations to obtain approval from their own lawmakers and to notify it no later than Dec. 31 next year. Once two-thirds of members have formally accepted it, the amendment will take effect in those states.
The IPO head said that final approval of the amendment could be settled in about two months.
“At present, 15 of the 151 WTO member states have notified the WTO of their acceptance, including the US, the EU, Japan, China, Australia and South Korea,” she said.
Wang said Taiwan will also have to revise its patent regulations to accommodate the new TRIPS regulations.
“The bureau has drafted a revision of the patent statute, which will also be reviewed by the legislature at some point,” she said.
Wang said that once the legal grounds for the amendment are established, Taiwan would be able to contribute more to the international community, particularly to poor countries that have little or no technological or financial ability to offer advanced medical treatment.
“With its advanced pharmaceutical ability, Taiwan could offer assistance especially to its 23 diplomatic alliances, most of which are underdeveloped countries,” she said.
The New Taiwan dollar is on the verge of overtaking the yuan as Asia’s best carry-trade target given its lower risk of interest-rate and currency volatility. A strategy of borrowing the New Taiwan dollar to invest in higher-yielding alternatives has generated the second-highest return over the past month among Asian currencies behind the yuan, based on the Sharpe ratio that measures risk-adjusted relative returns. The New Taiwan dollar may soon replace its Chinese peer as the region’s favored carry trade tool, analysts say, citing Beijing’s efforts to support the yuan that can create wild swings in borrowing costs. In contrast,
Nvidia Corp’s demand for advanced packaging from Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) remains strong though the kind of technology it needs is changing, Nvidia CEO Jensen Huang (黃仁勳) said yesterday, after he was asked whether the company was cutting orders. Nvidia’s most advanced artificial intelligence (AI) chip, Blackwell, consists of multiple chips glued together using a complex chip-on-wafer-on-substrate (CoWoS) advanced packaging technology offered by TSMC, Nvidia’s main contract chipmaker. “As we move into Blackwell, we will use largely CoWoS-L. Of course, we’re still manufacturing Hopper, and Hopper will use CowoS-S. We will also transition the CoWoS-S capacity to CoWos-L,” Huang said
VERTICAL INTEGRATION: The US fabless company’s acquisition of the data center manufacturer would not affect market competition, the Fair Trade Commission said The Fair Trade Commission has approved Advanced Micro Devices Inc’s (AMD) bid to fully acquire ZT International Group Inc for US$4.9 billion, saying it would not hamper market competition. As AMD is a fabless company that designs central processing units (CPUs) used in consumer electronics and servers, while ZT is a data center manufacturer, the vertical integration would not affect market competition, the commission said in a statement yesterday. ZT counts hyperscalers such as Microsoft Corp, Amazon.com Inc and Google among its major clients and plays a minor role in deciding the specifications of data centers, given the strong bargaining power of
TARIFF SURGE: The strong performance could be attributed to the growing artificial intelligence device market and mass orders ahead of potential US tariffs, analysts said The combined revenue of companies listed on the Taiwan Stock Exchange and the Taipei Exchange for the whole of last year totaled NT$44.66 trillion (US$1.35 trillion), up 12.8 percent year-on-year and hit a record high, data compiled by investment consulting firm CMoney showed on Saturday. The result came after listed firms reported a 23.92 percent annual increase in combined revenue for last month at NT$4.1 trillion, the second-highest for the month of December on record, and posted a 15.63 percent rise in combined revenue for the December quarter at NT$12.25 billion, the highest quarterly figure ever, the data showed. Analysts attributed the
RSS